Table 1.
Gene Name | Description | Reference |
---|---|---|
GBA | Loss of GBA function impairs autophagy via PPP2/PP2A inactivation. PD-associated mutation L444P heterozygote impairs autophagy, mitochondria priming and autophagy-lysosome degradation. |
[214,215] |
VPS13C | Deletion of VPS13C is correlated with impaired mitochondrial morphology and upregulate PINK1-PRKN-dependent mitophagy, but the study does not show the connection between PD-associated mutations with mitophagy. | [216] |
VPS35 | VPS35D620N causes autosomal-dominant Parkinson disease. VPS35D620N has a reduced affinity for WASH and impairs ATG9A trafficking and localization, thus compromising autophagosome formation. |
[217] |
VPS35D620N impairs endosome-to-Golgi retrieval of LAMP2A and accelerates LAMP2A degradation, thus inhibiting SNCA degradation through CMA. | [218] | |
VPS35D620N hampers PINK1 and PRKN recruitment to mitochondria thus impairing mitophagy. | [219] | |
PARK7 | PARK7 knockdown impairs autophagy and the SNCA uptake and degradation in microglia. | [220] |
PARK7 deficiency downregulates HSPA8 expression level and accelerates the degradation of LAMP2A, inhibiting SNCA degradation through CMA. | [221] | |
Park7 may function in mitophagy because it is important for proper mitochondria function and Park7 upregulation can rescue the phenotype in pink1 mutant Drosophila. | [222] | |
SREBF1 | SREBF1 knockdown inhibits PRKN translocation to mitochondria, thus inhibiting mitophagy. | [223] |
FBXO7 | FBXO7T22M inhibits its interaction with PRKN and impairs PRKN translocation to mitochondria. | [224] |
FBXO7R378G mutation impairs ubiquitination of MFN1. | ||
FBXO7R498X truncation inhibits PRKN recruitment to mitochondria. | ||
T22M, R378G and R498X mutations aggravate aggregation of FBXO7 in mitochondria, which may inhibit mitophagy. | [225] | |
TMEM175 | TMEM175 deficiency leads to the impaired autophagosome degradation in the lysosome. | [226] |
TMEM175M393T shows similar autophagosome clearance phenotype as a knockout. | [227] |